AVANOS MEDICAL, INC. Total Assets

• AVANOS MEDICAL, INC. showed a decrease of -7.0% in Total Assets from 2024 to 2025.
• This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2014: $2.45 billion | Q1 2015: $2.54 billion | Q2 2015: $2.49 billion | Q3 2015: $2.01 billion | Q1 2016: $2.02 billion | Q2 2016: $2.11 billion | Q3 2016: $2.10 billion | Q1 2017: $2.09 billion | Q2 2017: $2.12 billion | Q3 2017: $2.15 billion | Q1 2018: $2.20 billion | Q2 2018: $1.92 billion | Q3 2018: $1.84 billion | Q1 2019: $1.83 billion | Q2 2019: $1.78 billion | Q3 2019: $1.81 billion | Q1 2020: $1.76 billion | Q2 2020: $1.76 billion | Q3 2020: $1.80 billion | Q1 2021: $1.65 billion | Q2 2021: $1.68 billion | Q3 2021: $1.60 billion | Q1 2022: $1.77 billion | Q2 2022: $1.75 billion | Q3 2022: $1.78 billion | Q1 2023: $1.73 billion | Q2 2023: $1.67 billion | Q3 2023: $1.72 billion | Q1 2024: $1.66 billion | Q2 2024: $1.66 billion | Q3 2024: $1.66 billion | Q1 2025: $1.11 billion | Q2 2025: $1.04 billion | Q3 2025: $1.07 billion.
• Over the full 13 years of available data (2013 to 2025), AVANOS MEDICAL, INC.'s Total Assets has declined by 56.8%.
• Historical annual values: Fiscal year 2025: $1.07 billion | Fiscal year 2024: $1.15 billion | Fiscal year 2023: $1.69 billion | Fiscal year 2022: $1.79 billion | Fiscal year 2021: $1.60 billion | Fiscal year 2020: $1.67 billion | Fiscal year 2019: $1.80 billion | Fiscal year 2018: $1.83 billion | Fiscal year 2017: $2.20 billion | Fiscal year 2016: $2.07 billion | Fiscal year 2015: $2.00 billion | Fiscal year 2014: $2.52 billion | Fiscal year 2013: $2.48 billion.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026